Targeted Intracellular Delivery Summit

Kongressthemen
It has long been understood that the ability to deliver therapeutic cargos to cytosolic sites of action in target tissue could unlock access to previously undruggable targets, whilst enabling the development of safer and efficacious drugs.

Wissenschaftliche Fach-Gesellschaft
Hanson Wade

Anmerkungen
Brochure: https://go.evvnt.com/1443409-3?pid=4832

Speakers:Allen Horhota, Senior Director, Head of Delivery, Orna Therapeutics, Avidor Shulman, Chief Technology Officer, Biond Biologics, Ben Spangler, Senior Scientist, BioMarin Pharmaceutical & More

https://go.evvnt.com/1443409-2?pid=4832

Frau Emily Lincoln